Secretion rates and levels of vascular endothelial growth factor in clone A or HCT‐8 human colon tumour cells as a function of oxygen concentration

Molecular and in situ hybridization studies have shown, in a number of cell types, that under hypoxic conditions, vascular endothelial growth factor (VEGF) mRNA expression is up‐regulated and VEGF protein is concomitantly increased. To establish a quantitative relationship between VEGF protein levels and oxygenation, we exposed exponentially growing clone A or HCT‐8 human colon tumour cells in vitro (22 h at 37°C) to oxygen concentrations from 21% (air mixture) to 0.01%. Protein levels in cells and medium were then assayed using an enzyme‐linked immunoabsorbent assay (ELISA). Intracellular levels of VEGF in clone A or HCT‐8 cells exposed to either air (21% O2) or the 0.01% O2 mixture respectively increased from about 73 to 1270, and 1.5 to 1180 pg/106 cells (about 17‐ and 80‐fold increases). The shapes of the response curves (log of the intracellular VEGF concentrations v. log oxygen concentration) for both cell types were sigmoidal. However, intracellular VEGF levels in HCT‐8 cells were always less than that of clone A cells until levels of about 0.3 to 0.1% O2 were reached. Levels of VEGF in the supernatant were also increased after the 22 h hypoxic exposures. Because cell proliferation and clonogenicity were also measured, it was possible to estimate the secretion rates of VEGF for both cell lines as a function of oxygen percentage. For clone A cells, the secretion rate (pg/106 cells/h) in 21% O2 was 62.5. This rate increased to 428.8 pg/106 cells/h at 0.01% O2, a 7‐fold increase. For HCT‐8 cells, levels in the medium at 21% O2 were too low to be measured by ELISA. However, between 10% and 0.01% O2, secretion rates increased from 5.0 to 376.0 pg/106 cells/h, a 75‐fold increase. Therefore, at very low O2 levels, VEGF secretion rates were similar in the two cell lines. We propose that the different VEGF responses of clone A and HCT‐8 colon tumour cells to hypoxic stress in vitro are related to the in vivo observation that the respective hypoxic percentages of solid neoplasms originating from these cell lines are markedly different (i.e. about 3 versus 80%) at equivalent volumes of 750 mm3.

[1]  C. Haie-meder,et al.  Oxygen tension measurements in human tumors: The institut gustave-roussy experience , 1993 .

[2]  D. Marmé,et al.  Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor. , 1995, Biochemical and biophysical research communications.

[3]  A S Glicksman,et al.  Growth in solid heterogeneous human colon adenocarcinomas: comparison of simple logistical models , 1987, Cell and tissue kinetics.

[4]  J. Leith,et al.  Growth factors and growth control of heterogeneous cell populations. , 1993, Bulletin of mathematical biology.

[5]  Richard Treisman,et al.  Transcriptional Regulation by Extracellular signals: Mechanisms and Specificity , 1995, Cell.

[6]  J. Folkman,et al.  Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[7]  J. Leith,et al.  Changes in X-ray sensitivity and glutathione content of human colon tumor cells after exposure to the differentiation-inducing agent sodium butyrate. , 1988, Radiation research.

[8]  A. P. Reuvers,et al.  Studies on the Radiosensitizing Effect of Oxygen in Chinese Hamster Cells , 1974 .

[9]  J. Leith,et al.  Effect of preirradiation of transplantation site on growth characteristics and hypoxic fractions in human colon tumor xenografts. , 1992, Cancer research.

[10]  S. Kondo,et al.  Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. , 1994, Biochimica et biophysica acta.

[11]  R. Halaban,et al.  Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors. , 1993, Biochemical and biophysical research communications.

[12]  R. Weinmann,et al.  Characterization of hypoxia-responsive enhancer in the human erythropoietin gene shows presence of hypoxia-inducible 120-Kd nuclear DNA-binding protein in erythropoietin-producing and nonproducing cells. , 1993, Blood.

[13]  M. Goldberg,et al.  Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. , 1988, Science.

[14]  D. Dexter,et al.  Heterogeneity of cancer cells from a single human colon carcinoma. , 1981, The American journal of medicine.

[15]  H. Lederman,et al.  Effects of hypoxia on interleukin‐2 mRNA expression by T lymphocytes , 1994, Critical care medicine.

[16]  P. Hahnfeldt,et al.  Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression. , 1994, Cancer research.

[17]  J. Mitchell,et al.  The role of glutathione in radiation and drug induced cytotoxicity. , 1987, The British journal of cancer. Supplement.

[18]  J. Leith,et al.  Effects of feeder cells on the X-ray sensitivity of human colon cancer cells. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  Bing Li,et al.  Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.

[20]  H. Dvorak,et al.  Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. , 1992, Molecular biology of the cell.

[21]  Shay Soker,et al.  VEGF/VPF: The angiogenesis factor found? , 1993, Current Biology.

[22]  J. Leith,et al.  Dormancy, regression, and recurrence: towards a unifying theory of tumor growth control. , 1994, Journal of theoretical biology.

[23]  D. Zagzag Angiogenic growth factors in neural embryogenesis and neoplasia. , 1995, The American journal of pathology.

[24]  J. Fiddes,et al.  The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. , 1991, The Journal of biological chemistry.

[25]  Georg Breier,et al.  Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo , 1992, Nature.

[26]  G. Semenza,et al.  A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation , 1992, Molecular and cellular biology.

[27]  Y. Koga,et al.  Synthesis and release of interleukin 1 by reoxygenated human mononuclear phagocytes. , 1992, The Journal of clinical investigation.

[28]  J. Leith,et al.  Comparison of basic fibroblast growth factor levels in clone A human colon cancer cells in vitro with levels in xenografted tumours. , 1995, British Journal of Cancer.

[29]  J. Leith,et al.  Levels of selected growth factors in viable and necrotic regions of xenografted HCT‐8 human colon tumours , 1995, Cell proliferation.

[30]  G. P. van der Schans,et al.  The influence of oxygen on the induction of radiation damage in DNA in mammalian cells after sensitization by intracellular glutathione depletion. , 1986, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[31]  T. Maniatis,et al.  NF-κB: A lesson in family values , 1995, Cell.

[32]  J. Boag,et al.  Factors affecting the oxygen tension around cells growing in plastic Petri dishes. , 1970, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[33]  J. Caro,et al.  Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[34]  J. Leith,et al.  Hypoxic fractions in xenografted human colon tumors. , 1991, Cancer research.

[35]  K. Alitalo,et al.  Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. , 1994, The Journal of biological chemistry.

[36]  M. Goldberg,et al.  Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. , 1992, Blood.

[37]  A. Koong,et al.  Hypoxia Causes the Activation of Nuclear Factor κB through the Phosphorylation of IκBα on Tyrosine Residues , 1994 .

[38]  J. Leith,et al.  Interlocking triads of growth control in tumors. , 1995, Bulletin of mathematical biology.

[39]  G. Papa,et al.  Modification of the volumetric growth responses and steady-state hypoxic fractions of xenografted DLD-2 human colon carcinomas by administration of basic fibroblast growth factor or suramin. , 1992, British Journal of Cancer.

[40]  C. Koch A thin-film culturing technique allowing rapid gas-liquid equilibration (6 sec) with no toxicity to mammalian cells. , 1984, Radiation research.

[41]  B. Henderson,et al.  Effect of DL-buthionine-S,R-sulfoximine on the growth of EMT6 and RIF mouse tumors. , 1986, Journal of the National Cancer Institute.

[42]  Goldman,et al.  Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. , 1993, Molecular biology of the cell.

[43]  E. Goldwasser,et al.  Expression of the erythropoietin gene. , 1986, Blood cells.

[44]  M. Goldberg,et al.  Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. , 1994, The Journal of biological chemistry.

[45]  J. Leith,et al.  Effects of administration of basic fibroblast growth factor on hypoxic fractions in xenografted DLD-2 human tumours: time dependence. , 1993, British Journal of Cancer.

[46]  D. Charnock-Jones,et al.  Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. , 1995, Journal of the National Cancer Institute.

[47]  E. Rofstad Radiation biology of human tumour xenografts. , 1989, International journal of radiation biology.

[48]  S. Rockwell,et al.  Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. , 1984, International journal of radiation oncology, biology, physics.

[49]  R. Durand,et al.  Respiration-induced oxygen gradients in cultured mammalian cells. , 1990, International journal of radiation biology.

[50]  M. Koury,et al.  Anemia induces accumulation of erythropoietin mRNA in the kidney and liver. , 1986, Molecular and cellular biology.

[51]  P. Ghezzi,et al.  Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. , 1991, Cytokine.

[52]  T. Standiford,et al.  Anoxia-hyperoxia induces monocyte-derived interleukin-8. , 1992, The Journal of clinical investigation.

[53]  J. Leith,et al.  Modification of the growth rates and hypoxic fractions of xenografted A431 tumors by sialoadenectomy or exogenously supplied epidermal growth factor. , 1991, Cancer research.

[54]  A. Ullrich,et al.  Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant , 1994, Nature.

[55]  Elizabeth C. Theil Regulation of ferritin and transferrin receptor mRNAs. , 1990, The Journal of biological chemistry.

[56]  J. Leith,et al.  Changes in the extents of viable and necrotic tissue, interstitial fluid pressure, and proliferation kinetics in clone A human colon tumour xenografts as a function of tumour size , 1994 .

[57]  J. Leith,et al.  Autocrine and paracrine growth factors in tumor growth: a mathematical model. , 1991, Bulletin of mathematical biology.

[58]  P. Ratcliffe,et al.  Inducible operation of the erythropoietin 3' enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[59]  D. Faller,et al.  Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. , 1991, The Journal of clinical investigation.

[60]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[61]  R. Weinmann,et al.  Enhancer element at the 3'-flanking region controls transcriptional response to hypoxia in the human erythropoietin gene. , 1991, The Journal of biological chemistry.